MMJ Recs

MAY 9, 2024

There are multiple US states with an established state-approved medical marijuana program as well as states permitting the use of cannabinol (CBD) oil – a non-psychoactive component of cannabis – for medical purposes exclusively.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

SEPTEMBER 23, 2022

SB 57 – which passed both houses – would have created a pilot program for overdose prevention sites in San Francisco, Oakland, and Los Angeles as an evidence-based intervention to curb drug overdose deaths. The continued criminalization of all drugs and the people who use them increases harms to public health and safety. ABOUT MAPS.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Cannabis Law Report

OCTOBER 20, 2021

The CBD brand FullSend claims Nelk has conducted an “enforcement program” to put it out of business by threatening it with litigation and demanding it stop selling and advertising its products under what FullSend claims is its own mark. Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution.

Legislation 124

Legislation Clinical Trials Research and Development Access 124

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. A 2016 study published in the Journal of School Health concluded alcohol use should be a target of school abuse prevention programs.

Data 186

Data Clinical Trials Chronic Pain Medicine 186